FDA, Austen BioInnovation Institute to Collaborate on the Safety, Performance of Materials Used in Medical Devices

Austen BioInnovation Institute in Akron and the U.S. Food and Drug Administration have entered into a ground-breaking collaboration to support and develop regulatory science for the safe and effective use of biomaterials in medical devices.
Medical Design Online